Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China · Delayed Price · Currency is CNY 27.46
-0.34 (-1.22%)
Sep 30, 2026, 3:00 PM CST
SHA:688566 Revenue
Jiangsu Jibeier Pharmaceutical had revenue of 263.14M CNY in the quarter ending June 30, 2026, with 3.96% growth. This brings the company's revenue in the last twelve months to 1.00B, up 9.03% year-over-year. In the year 2025, Jiangsu Jibeier Pharmaceutical had annual revenue of 966.07M with 7.76% growth.
Revenue (ttm)
1.00B
Revenue Growth
+9.03%
P/S Ratio
5.52
Revenue / Employee
725.15K
Employees
1,380
Market Cap
5.52B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 966.07M | 69.53M | 7.76% |
| Dec 31, 2024 | 896.53M | 35.60M | 4.14% |
| Dec 31, 2023 | 860.93M | 206.20M | 31.49% |
| Dec 31, 2022 | 654.73M | 145.04M | 28.46% |
| Dec 31, 2021 | 509.69M | -56.28M | -9.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsJiangsu Jibeier Pharmaceutical News
- 5 weeks ago - Jiangsu Jibeier Pharmaceutical Quarterly report: Q2 2026 - Filings
- 5 months ago - Jiangsu Jibeier Pharmaceutical Annual report: Q4 2025 - Filings
- 5 months ago - Jiangsu Jibeier Pharmaceutical Quarterly report: Q1 2026 - Filings
- 11 months ago - Jiangsu Jibeier Pharmaceutical Quarterly report: Q3 2025 - Filings